Discover convenient tools and helpful tips related to using USP Reference Standards in your work. USP Reference Standards are intended for quality control use in conducting assays and tests in USP’s documentary standards for drugs, dietary supplements, and foods.
In conversations about the role of quality standards in public health, you might come across the words “compendia” and “compendial.” At USP, terms like “compendial approaches,” “compendial standards,” and “compendial tools” are part of our everyday vocabulary.
Quality plays an integral role in connecting medical research and manufacturing to healthcare practice and consumers. The growing study of the microbiome and the potential health benefits of probiotics offers a particularly timely and illustrative example. Learn about the quality standards USP has developed for probiotics and how they could be the unifying thread connecting clinical research to academia, industry and patients/consumers.
Thank you for helping Quality Matters spread the word in 2015 about USP quality standards and the important role our work plays in industry, public health and lives around the world. These five posts are the ones that you, our readers, found to be the most engaging and useful in 2015.
The FDA has given the food industry up to three years to remove partially hydrogenated oils (PHOs) from the human food supply. In recent years, fully hydrogenated oils and fats (FHOs) have been used as an alternative to PHOs but there are no public monographs with definitions of FHOs to help ensure buyers that ingredients meet prescribed measures for composition and purity.
Manufacturers often rely on trusted suppliers to provide quality ingredients. But is trust enough? Not anymore. In today’s world of increasingly complex global supply chains, it’s okay to trust, so long as you verify.
Intentional deception using food for economic gain, or food fraud, has been an ongoing challenge since the beginning of the food and drink industry.
Margaret Hamburg is approaching the end of a successful six-year tenure as Commissioner of the U.S. Food and Drug Administration. USP extends its congratulations to Dr. Hamburg in this letter from CEO Ron Piervincenzi.